<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Omar | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/bettyrussia14/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/bettyrussia14/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Omar.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">1bc5d87d9f169a14c92c5da6139c8600</guid>
				<title>Omar posted an update: coli at inhibition zone diameters of 8.3 mm, and 8.0 mm, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42765/</link>
				<pubDate>Sun, 09 Feb 2025 11:17:28 -0800</pubDate>

									<content:encoded><![CDATA[<p>coli at inhibition zone diameters of 8.3 mm, and 8.0 mm, respectively, while ethyl acetate fraction was against S. aureus with an inhibition zone of 8.7 mm. Methanolic fraction exhibited broad-spectrum activity against 87.5% of the tested microbes (inhibition zones 6.3-8.3 mm). Furthermore, we qualitatively detected terpenoids, alkaloids, and&hellip;<span class="activity-read-more" id="activity-read-more-42765"><a href="http://www.nationalboardinstitute.com/activity/p/42765/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c600ab0d05ae2f12929761c2b36bca22</guid>
				<title>Omar posted an update: There was also a significant increase in the expression of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41951/</link>
				<pubDate>Sat, 08 Feb 2025 11:39:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>There was also a significant increase in the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the expression of the BBB-related tight junction protein, Zonula occludens-1 (ZO-1). These results indicate a disturbance of BBB integrity. Quantitative proteomic analysis showed significant alterations in pathways&hellip;<span class="activity-read-more" id="activity-read-more-41951"><a href="http://www.nationalboardinstitute.com/activity/p/41951/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4676adc3bb047375b57d336c81de89e6</guid>
				<title>Omar posted an update: criteria with were not treated appropriately. It is critical [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40144/</link>
				<pubDate>Thu, 06 Feb 2025 13:35:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>criteria with were not treated appropriately. It is critical that clinicians should be aware of the diagnosis of NS and treat patients appropriately.Efforts to mitigate global warming are often justified through calculations of the economic damages that may occur absent mitigation. The earliest such damage estimates were speculative mathematical&hellip;<span class="activity-read-more" id="activity-read-more-40144"><a href="http://www.nationalboardinstitute.com/activity/p/40144/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cebe98fe24a1d77ca6bd1c9659edc770</guid>
				<title>Omar posted an update: Purpose Rivastigmine hydrogen tartrate (RHT) is commonly [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38388/</link>
				<pubDate>Tue, 04 Feb 2025 11:21:24 -0800</pubDate>

									<content:encoded><![CDATA[<p>Purpose Rivastigmine hydrogen tartrate (RHT) is commonly used for the treatment of mild to moderate Alzheimer&#8217;s disease (AD). The aim of this work was to formulate in-situ pluronic F-127 (PF-127) hydrogels containing Eudragit RL-100 (EU-RL) nanoparticles (NPs) in order to improve the therapeutic efficacy of RHT through the nasal route. Methods The&hellip;<span class="activity-read-more" id="activity-read-more-38388"><a href="http://www.nationalboardinstitute.com/activity/p/38388/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">268edd198bcd792539792a367dba0564</guid>
				<title>Omar posted an update: resilient health systems.



 Despite widespread interest in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37564/</link>
				<pubDate>Mon, 03 Feb 2025 11:22:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>resilient health systems.</p>
<p> Despite widespread interest in the use of virtual (ie, telephone and video) visits for ambulatory patient care during the COVID-19 pandemic, studies examining their adoption during the pandemic by race, sex, age, or insurance are lacking. Moreover, there have been limited evaluations to date of the impact of these&hellip;<span class="activity-read-more" id="activity-read-more-37564"><a href="http://www.nationalboardinstitute.com/activity/p/37564/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dd990735fcf334038317e406c123854d</guid>
				<title>Omar posted an update: Mean specialist response times decreased from 5.9±4.9 min [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36675/</link>
				<pubDate>Sun, 02 Feb 2025 11:36:31 -0800</pubDate>

									<content:encoded><![CDATA[<p>Mean specialist response times decreased from 5.9±4.9 min (2008-2012, mean±SD) to 4.3±2.2 min (2016-2019, p=0.12), and the number of incidents with response times &gt;5 min decreased from 28.8±17.8% (2008-2012) to 9.3±11.4% (2016-2019, p=0.04 by linear regression). As our program became more standardized, we noted better equipment availability and&hellip;<span class="activity-read-more" id="activity-read-more-36675"><a href="http://www.nationalboardinstitute.com/activity/p/36675/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8c0c7a28293d83f45e2605e8c0e67177</guid>
				<title>Omar posted an update: Recently, progression of chronic renal failure (CRF) has [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35877/</link>
				<pubDate>Sat, 01 Feb 2025 11:43:01 -0800</pubDate>

									<content:encoded><![CDATA[<p>Recently, progression of chronic renal failure (CRF) has been closely associated with gut microbiota dysbiosis and intestinal metabolite-derived microinflammation. In China, total flavones of </p>
<p> (TFA), a component of </p>
<p> , has been widely used to delay CRF progression in clinics for the past two decades. However, the overall therapeutic&hellip;<span class="activity-read-more" id="activity-read-more-35877"><a href="http://www.nationalboardinstitute.com/activity/p/35877/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c448f22a29929548276394aeb9f93749</guid>
				<title>Omar posted an update: With the widespread development of new drugs to treat [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33974/</link>
				<pubDate>Thu, 30 Jan 2025 11:30:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>With the widespread development of new drugs to treat chronic liver diseases (CLDs), including viral hepatitis and nonalcoholic steatohepatitis (NASH), more patients are entering trials with abnormal baseline liver tests and with advanced liver injury, including cirrhosis. The current regulatory guidelines addressing the monitoring, diagnosis, and&hellip;<span class="activity-read-more" id="activity-read-more-33974"><a href="http://www.nationalboardinstitute.com/activity/p/33974/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0a21ea1b0c0f155c4d9a5c3b08c1bb9a</guid>
				<title>Omar posted an update: Compared to controls, the ADHD groups showed hypoactivation [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29399/</link>
				<pubDate>Tue, 28 Jan 2025 13:07:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>Compared to controls, the ADHD groups showed hypoactivation in motor/sensory cortices and hyperactivation in frontal pole and OFC during reward outcome. ADHD + SM also showed hyperactivation in frontal pole during neutral outcome. Moreover, ADHD + SM patients showed higher callous-unemotional (CU) traits that were positively correlated with pu&hellip;<span class="activity-read-more" id="activity-read-more-29399"><a href="http://www.nationalboardinstitute.com/activity/p/29399/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5f914a048e2314cfb53fca0000b74281</guid>
				<title>Omar became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29296/</link>
				<pubDate>Tue, 28 Jan 2025 13:02:16 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>